ChAdOx1 nCoV-19
A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
Year introduced: 2022(2021)
PubMed search builder options
Subheadings:
Tree Number(s): D20.215.894.865.450.250.500, D20.215.894.899.085.063
MeSH Unique ID: D000090985
Registry Number: B5S3K2V0G8
Entry Terms:
- ChAdOx1 nCoV 19
- nCoV-19, ChAdOx1
- Oxford-AstraZeneca COVID Vaccine
- COVID Vaccine, Oxford-AstraZeneca
- Oxford AstraZeneca COVID Vaccine
- Vaccine, Oxford-AstraZeneca COVID
- Oxford-AstraZeneca COVID-19 Vaccine
- COVID-19 Vaccine, Oxford-AstraZeneca
- Oxford AstraZeneca COVID 19 Vaccine
- Vaccine, Oxford-AstraZeneca COVID-19
- ChAdOx1 COVID-19 Vaccine
- ChAdOx1 COVID 19 Vaccine
- COVID-19 Vaccine, ChAdOx1
- Vaccine, ChAdOx1 COVID-19
- COVID-19 Vaccine AstraZeneca
- AstraZeneca, COVID-19 Vaccine
- COVID 19 Vaccine AstraZeneca
- AZD1222
- AZD-1222
- AZD 1222
- Covishield
- Vaxzevria